anesthesia
Conditions
Interventions
control group:propofol
experiment group 1:propofol and 1.25ug/ml remifentail
experiment group 2:propofol and 2.5ug/ml remifentail
experiment group 3:propofol and 5ug/ml remifentail
Sponsors
The Affiliated Hospital of Nantong University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult outpatients undergoing elective gastroscopy and sedated with propofol were enrolled in this study.
Exclusion criteria
Exclusion criteria: (1) coagulation disorders attendency for nose bleeding; (2) an episode/exacerbation of congestive heart failure that required a change in medication, diet, or hospitalization from any cause in the last 6 months; (3) severe aortic stenosis or mitral stenosis; (4) cardiac surgery involving thoracotomy (eg, coronary artery bypass graft or valve replacement surgery) in the last 6 months; (5) acute myocardial infarction in the last 6 months; (6) acute arrhythmia (including tachycardia and bradycardia) with hemodynamic instability; (7) diagnosed chronic obstructive pulmonary disease (COPD) or other current acute or chronic lung diseases requiring sup-plemental chronic or intermittent oxygen therapy; (8) increased intracranial pressure; (9) America Society of Anesthesiologists (ASA) class >III; (10) mouth, nose, or throat infection; (11) fever, defined as core body temperature >37.5 degree C; (12) pregnancy, breastfeeding, or positive pregnancy test; and (13) emergency procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dose of propofol; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of hypoxia;Recovery time; | — |
Countries
China
Contacts
Public ContactChaochao Zhong
The Affiliated Hospital of Nantong University
Outcome results
None listed